Adaptimmune Therapeutics PLC financial data

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Adaptimmune Ltd (to 3/17/2015)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 301 % -23.4%
Debt-to-equity 324 % +48.6%
Return On Assets -55.4 % -62.2%
Operating Margin -1.04 K % -558%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.48 B shares +49.3%
Common Stock, Shares, Outstanding 1.53 B shares +54.3%
Entity Public Float 191 M USD -21.7%
Common Stock, Value, Issued 2.08 M USD +47.9%
Weighted Average Number of Shares Outstanding, Basic 1.45 B shares +46.4%
Weighted Average Number of Shares Outstanding, Diluted 1.45 B shares +45.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68 M USD -88.1%
Revenue from Contract with Customer, Excluding Assessed Tax 18.4 M USD -74.2%
Research and Development Expense 136 M USD +16.9%
General and Administrative Expense 72.8 M USD +8.76%
Costs and Expenses 209 M USD +13.9%
Operating Income (Loss) -191 M USD -69.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -162 M USD -45.2%
Income Tax Expense (Benefit) 1.24 M USD -50.3%
Net Income (Loss) Attributable to Parent -163 M USD -43.1%
Earnings Per Share, Basic -0.12 USD/shares 0%
Earnings Per Share, Diluted -0.12 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 141 M USD +17.4%
Accounts Receivable, after Allowance for Credit Loss, Current 8.4 M USD +390%
Other Assets, Current 2.84 M USD +70.5%
Assets, Current 187 M USD -12.6%
Property, Plant and Equipment, Net 48.3 M USD -11.2%
Operating Lease, Right-of-Use Asset 19.4 M USD +8.29%
Intangible Assets, Net (Excluding Goodwill) 524 K USD +18.3%
Assets 258 M USD -10.4%
Accounts Payable, Current 6.59 M USD +27%
Employee-related Liabilities, Current 6.25 M USD +30.7%
Accrued Liabilities, Current 23.1 M USD -30.6%
Contract with Customer, Liability, Current 31.5 M USD +41.3%
Liabilities, Current 66.4 M USD +4.37%
Contract with Customer, Liability, Noncurrent 147 M USD +23.6%
Operating Lease, Liability, Noncurrent 18.4 M USD -7.75%
Other Liabilities, Noncurrent 1.42 M USD +6.38%
Liabilities 234 M USD +14.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.72 M USD -52.4%
Retained Earnings (Accumulated Deficit) -1.07 B USD -18%
Stockholders' Equity Attributable to Parent 24.4 M USD -70.9%
Liabilities and Equity 258 M USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32 M USD +14.3%
Net Cash Provided by (Used in) Financing Activities 29.2 M USD +14816%
Net Cash Provided by (Used in) Investing Activities -358 K USD -101%
Common Stock, Shares Authorized 1.7 B shares +32.7%
Common Stock, Shares, Issued 1.53 B shares +54.3%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49 M USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 144 M USD +18.2%
Deferred Tax Assets, Valuation Allowance 295 M USD +83.7%
Deferred Tax Assets, Gross 302 M USD +82.2%
Operating Lease, Liability 23.7 M USD +3.76%
Depreciation 2.77 M USD +67%
Payments to Acquire Property, Plant, and Equipment 102 K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164 M USD -54.1%
Lessee, Operating Lease, Liability, to be Paid 28.3 M USD -0.49%
Property, Plant and Equipment, Gross 97 M USD +5.28%
Operating Lease, Liability, Current 5.25 M USD +84.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.56 M USD +38.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.19 M USD +58.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.62 M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.36 M USD +7.68%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.56 M USD +35.5%
Additional Paid in Capital 1.1 B USD +10.5%
Amortization of Intangible Assets 4.21 M USD
Deferred Tax Assets, Net of Valuation Allowance 7.1 M USD +34.8%
Share-based Payment Arrangement, Expense 13.2 M USD -7.89%